MorphoSys AG
ANTIBODIES TARGETING C5AR
Last updated:
Abstract:
The present invention provides novel antibodies or antibody fragments specifically binding to human C5aR. In particular, it relates to antibodies or antibody fragments that have combined beneficial properties and are therefore useful for the treatment of inflammatory or autoimmune diseases or cancer.
Status:
Application
Type:
Utility
Filling date:
13 Mar 2020
Issue date:
5 May 2022